Ryan Specialty (RYAN) Financials

$73.08 -1.12 (-1.51%)

Closing price 03:59 PM Eastern

Extended Trading

$73.09 +0.01 (+0.02%)

As of 04:20 PM Eastern

Annual Income Statements for Ryan Specialty

This table shows Ryan Specialty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	64	68	66	61	61	95
Consolidated Net Income / (Loss)	63	71	57	163	194	230
Net Income / (Loss) Continuing Operations	63	71	57	163	194	230
Total Pre-Tax Income	68	79	62	179	238	273
Total Operating Income	101	159	187	290	359	428
Total Gross Profit	765	1,018	1,433	1,725	2,078	2,516
Total Revenue	765	1,018	1,433	1,725	2,078	2,516
Operating Revenue	765	1,018	1,433	1,725	2,078	2,516
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00
Total Operating Expenses	664	860	1,246	1,436	1,718	2,088
Selling, General & Admin Expense	118	107	139	197	276	352
Depreciation Expense	4.80	3.93	4.81	5.69	9.04	9.79
Amortization Expense	48	64	108	104	107	158
Other Operating Expenses / (Income)	494	686	992	1,129	1,321	1,591
Other Special Charges / (Income)	-1.60	-1.30	2.89	0.44	5.42	-23
Total Other Income / (Expense), net	-33	-79	-125	-110	-121	-155
Interest & Investment Income	-0.98	0.44	-0.76	-105	-111	-140
Other Income / (Expense), net	3.47	-32	-45	-5.07	-10	-15
Income Tax Expense	4.93	8.95	4.93	16	43	43
Net Income / (Loss) Attributable to Noncontrolling Interest	-1.11	2.41	-9.24	102	133	135
Basic Earnings per Share	$0.00	$0.00	($0.07)	$0.57	$0.53	$0.78
Weighted Average Basic Shares Outstanding	0.00	0.00	105.73M	108.62M	114.36M	120.78M
Diluted Earnings per Share	$0.00	$0.00	($0.07)	$0.52	$0.52	$0.71
Weighted Average Diluted Shares Outstanding	0.00	0.00	105.73M	265.75M	125.75M	132.89M
Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	105.73M	519.30M	520.45M	261.91M
Cash Dividends to Common per Share	-	-	-	-	-	$0.04

This table shows Ryan Specialty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	12	18	13	30	-5.05	23	17	47	18	14
Consolidated Net Income / (Loss)	29	46	36	84	16	59	41	118	29	43
Net Income / (Loss) Continuing Operations	29	46	36	84	16	59	41	118	29	43
Total Pre-Tax Income	33	52	43	95	41	59	47	137	20	69
Total Operating Income	61	79	70	123	70	96	73	164	81	109
Total Gross Profit	412	435	458	585	502	533	552	695	605	664
Total Revenue	412	435	458	585	502	533	552	695	605	664
Operating Revenue	412	435	458	585	502	533	552	695	605	664
Total Operating Expenses	351	356	388	462	432	437	479	531	523	554
Selling, General & Admin Expense	49	57	52	82	69	74	76	83	89	105
Depreciation Expense	1.46	1.79	2.19	2.18	2.20	2.47	2.08	2.27	2.47	2.97
Amortization Expense	26	25	25	24	30	28	28	31	39	60
Other Operating Expenses / (Income)	274	271	308	352	329	332	374	414	393	410
Other Special Charges / (Income)	0.42	1.28	0.71	1.80	1.85	1.06	-0.07	1.24	-0.37	-24
Total Other Income / (Expense), net	-29	-28	-27	-27	-29	-37	-26	-28	-62	-40
Interest & Investment Income	0.14	-105	2.00	1.62	-29	-85	5.61	3.72	-45	-104
Other Income / (Expense), net	0.07	1.76	0.14	-0.11	-0.07	-10	-1.75	-0.23	-17	3.53
Income Tax Expense	3.41	5.86	6.30	12	25	0.67	6.43	19	-8.96	26
Net Income / (Loss) Attributable to Noncontrolling Interest	18	28	23	54	21	36	24	71	11	29
Basic Earnings per Share	$0.11	$0.16	$0.12	$0.27	($0.04)	$0.18	$0.14	$0.38	$0.15	$0.11
Weighted Average Basic Shares Outstanding	109.43M	108.62M	111.03M	112.92M	115.87M	114.36M	117.81M	118.39M	121.92M	120.78M
Diluted Earnings per Share	$0.09	$0.15	$0.11	$0.26	($0.04)	$0.19	$0.13	$0.37	$0.09	$0.12
Weighted Average Diluted Shares Outstanding	266.35M	265.75M	266.98M	123.85M	115.87M	125.75M	269.92M	271.22M	272.69M	132.89M
Weighted Average Basic & Diluted Shares Outstanding	519.21M	519.30M	519.56M	520.43M	520.50M	520.45M	520.89M	522.90M	261.84M	261.91M

This table details how cash moves in and out of Ryan Specialty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	237	492	244	628	-11	-76
Net Cash From Operating Activities	150	135	273	336	477	515
Net Cash From Continuing Operating Activities	165	135	273	336	477	515
Net Income / (Loss) Continuing Operations	63	71	57	163	194	230
Consolidated Net Income / (Loss)	63	71	57	163	194	230
Depreciation Expense	4.80	3.93	4.81	5.69	9.04	9.79
Amortization Expense	50	69	119	120	126	189
Non-Cash Adjustments To Reconcile Net Income	28	34	123	112	103	99
Changes in Operating Assets and Liabilities, net	20	-41	-31	-66	45	-13
Net Cash From Investing Activities	-148	-769	-458	-22	-476	-1,756
Net Cash From Continuing Investing Activities	-148	-769	-458	-22	-476	-1,756
Purchase of Property, Plant & Equipment	-8.09	-18	-353	-23	-30	-47
Acquisitions	-121	-718	-109	0.00	-447	-1,709
Other Investing Activities, net	-8.51	-9.31	3.89	0.34	0.23	0.00
Net Cash From Financing Activities	62	1,125	429	315	-13	1,167
Net Cash From Continuing Financing Activities	220	1,125	429	315	-13	1,167
Repayment of Debt	-267	-983	-20	-19	-17	-1,284
Payment of Dividends	-	-	-	-40	-72	-185
Issuance of Debt	421	1,956	0.00	394	0.00	2,545
Other Financing Activities, net	66	152	44	-20	76	91
Effect of Exchange Rate Changes	0.27	-	-	-0.13	0.58	-1.51

This table details how cash moves in and out of Ryan Specialty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-140	229	-294	479	-350	153	-135	123	-388	325
Net Cash From Operating Activities	-14	185	-159	304	105	227	-117	271	101	260
Net Cash From Continuing Operating Activities	-14	185	-159	304	105	227	-117	271	101	260
Net Income / (Loss) Continuing Operations	29	46	36	84	16	59	41	118	29	43
Consolidated Net Income / (Loss)	29	46	36	84	16	59	41	118	29	43
Depreciation Expense	1.46	1.79	2.19	2.18	2.20	2.47	2.08	2.27	2.47	2.97
Amortization Expense	30	30	30	29	34	32	33	35	56	64
Non-Cash Adjustments To Reconcile Net Income	27	16	18	19	41	24	13	23	38	25
Changes in Operating Assets and Liabilities, net	-102	91	-246	169	12	109	-205	92	-25	125
Net Cash From Investing Activities	-4.90	-11	-105	-4.42	-273	-94	-7.63	-229	-1,050	-469
Net Cash From Continuing Investing Activities	-4.90	-11	-105	-4.42	-273	-94	-7.63	-229	-1,050	-469
Purchase of Property, Plant & Equipment	-5.23	-11	-2.79	-2.57	-11	-14	-7.63	-15	-7.10	-17
Acquisitions	-	-	-102	-1.87	-262	-81	0.00	-214	-1,043	-452
Net Cash From Financing Activities	-119	54	-30	180	-183	19	-10	82	553	542
Net Cash From Continuing Financing Activities	-119	54	-30	180	-183	19	-10	82	553	542
Repayment of Debt	-4.13	-4.16	-4.13	-4.13	-4.13	-4.13	0.00	-8.25	-867	-409
Payment of Dividends	-6.46	-7.21	-0.26	-34	-18	-19	-46	-63	-40	-36
Issuance of Debt	-	-	-	-	-	-	-	-	-	992
Other Financing Activities, net	-109	66	-25	219	-161	43	35	154	-93	-5.87
Effect of Exchange Rate Changes	-1.63	1.15	0.09	-0.74	-0.17	1.41	-0.66	-1.35	7.65	-7.16

This table presents Ryan Specialty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Total Assets	4,529	5,459	6,384	7,247	9,650
Total Current Assets	2,493	3,011	3,894	4,336	4,789
Cash & Equivalents	313	387	993	839	540
Accounts Receivable	178	210	231	294	390
Prepaid Expenses	8.84	7.73	8.58	8.72	9.22
Other Current Assets	1,994	2,406	2,661	3,194	3,850
Plant, Property, & Equipment, net	17	15	31	42	50
Total Noncurrent Assets	2,019	2,432	2,458	2,869	4,811
Long-Term Investments	47	45	39	46	71
Goodwill	1,224	1,309	1,315	1,646	2,647
Intangible Assets	605	574	486	611	1,476
Noncurrent Deferred & Refundable Income Taxes	0.00	383	397	384	448
Other Noncurrent Operating Assets	142	121	222	182	169
Total Liabilities & Shareholders' Equity	4,529	5,459	6,384	7,247	9,650
Total Liabilities	4,219	4,864	5,566	6,268	8,552
Total Current Liabilities	2,482	2,918	3,134	3,744	4,549
Short-Term Debt	19	23	31	35	52
Accounts Payable	116	99	119	136	249
Accrued Expenses	350	386	350	420	486
Other Current Liabilities	1,998	2,409	2,634	3,153	3,762
Total Noncurrent Liabilities	1,736	1,946	2,432	2,523	4,003
Long-Term Debt	1,566	1,567	1,952	1,944	3,231
Noncurrent Deferred & Payable Income Tax Liabilities	0.58	273	295	359	476
Noncurrent Employee Benefit Liabilities	69	4.37	10	25	49
Other Noncurrent Operating Liabilities	100	102	174	196	246
Total Equity & Noncontrolling Interests	71	595	818	980	1,098
Total Preferred & Common Equity	70	344	478	560	628
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	70	344	478	560	628
Common Stock	67	349	418	442	507
Retained Earnings	0.00	-7.06	54	114	123
Accumulated Other Comprehensive Income / (Loss)	2.70	1.71	6.04	3.08	-1.80
Noncontrolling Interest	1.30	251	339	420	471

This table presents Ryan Specialty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	5,688	6,047	7,236	6,426	7,117	8,272	8,479
Total Current Assets	3,200	3,469	4,659	3,586	4,216	5,123	4,019
Cash & Equivalents	833	705	966	754	665	612	235
Accounts Receivable	187	235	301	239	299	384	335
Prepaid Expenses	7.78	8.35	8.00	9.58	8.15	8.05	8.31
Other Current Assets	2,171	2,521	3,384	2,584	3,244	4,118	3,441
Plant, Property, & Equipment, net	23	32	33	32	43	46	46
Total Noncurrent Assets	2,466	2,546	2,544	2,807	2,857	3,104	4,413
Long-Term Investments	39	41	44	45	56	59	62
Goodwill	1,314	1,379	1,379	1,582	1,647	1,815	2,341
Intangible Assets	501	515	494	592	592	673	1,353
Noncurrent Deferred & Refundable Income Taxes	399	402	415	383	383	379	486
Other Noncurrent Operating Assets	213	209	212	205	180	179	171
Total Liabilities & Shareholders' Equity	5,688	6,047	7,236	6,426	7,117	8,272	8,479
Total Liabilities	4,930	5,195	6,292	5,485	6,142	7,199	7,377
Total Current Liabilities	2,518	2,767	3,827	2,982	3,677	4,696	3,966
Short-Term Debt	29	22	31	36	39	33	33
Accounts Payable	82	74	96	115	231	172	206
Accrued Expenses	233	158	337	273	184	398	325
Current Deferred & Payable Income Tax Liabilities	-	-	-	17	22	22	23
Other Current Liabilities	2,174	2,512	3,364	2,541	3,201	4,071	3,379
Total Noncurrent Liabilities	2,413	2,429	2,464	2,503	2,464	2,503	3,411
Long-Term Debt	1,953	1,950	1,949	1,945	1,943	1,941	2,647
Noncurrent Deferred & Payable Income Tax Liabilities	295	288	310	342	339	345	454
Noncurrent Employee Benefit Liabilities	9.07	16	18	22	30	62	52
Other Noncurrent Operating Liabilities	155	174	187	193	153	156	259
Total Equity & Noncontrolling Interests	758	852	944	941	975	1,073	1,102
Total Preferred & Common Equity	443	509	559	543	554	606	633
Preferred Stock	-	-	-	0.00	0.00	0.00	0.00
Total Common Equity	443	509	559	543	554	606	633
Common Stock	402	437	453	443	460	478	501
Retained Earnings	36	67	97	92	89	122	125
Accumulated Other Comprehensive Income / (Loss)	4.37	4.28	8.53	8.24	6.10	5.90	7.08
Noncontrolling Interest	315	343	385	398	420	467	469

This table displays calculated financial ratios and metrics derived from Ryan Specialty's official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	33.09%	40.71%	20.41%	20.42%	21.09%
EBITDA Growth	0.00%	24.89%	33.69%	54.45%	17.85%	26.39%
EBIT Growth	0.00%	20.82%	12.20%	100.76%	22.59%	18.37%
NOPAT Growth	0.00%	50.11%	22.03%	53.64%	11.28%	22.95%
Net Income Growth	0.00%	11.82%	-19.69%	188.28%	19.13%	18.22%
EPS Growth	0.00%	0.00%	0.00%	842.86%	0.00%	36.54%
Operating Cash Flow Growth	0.00%	-9.44%	102.00%	22.68%	42.23%	7.89%
Free Cash Flow Firm Growth	0.00%	0.00%	96.80%	654.09%	-104.61%	-11,620.62%
Invested Capital Growth	0.00%	0.00%	14.08%	0.95%	17.24%	81.78%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	3.38%	4.94%	5.48%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	40.37%	1.75%	10.65%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	69.12%	1.45%	6.96%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	10.02%	8.79%	-7.05%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	10.99%	7.00%	-6.49%
EPS Q/Q Growth	0.00%	0.00%	0.00%	13.04%	8.33%	-8.97%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-4.87%	24.22%	9.74%	6.80%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-172.86%	-37.25%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-5.32%	-2.29%	8.22%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	20.80%	19.52%	18.55%	23.79%	23.28%	24.30%
Operating Margin	13.21%	15.57%	13.03%	16.78%	17.28%	17.01%
EBIT Margin	13.66%	12.40%	9.89%	16.49%	16.78%	16.41%
Profit (Net Income) Margin	8.24%	6.92%	3.95%	9.46%	9.36%	9.14%
Tax Burden Percent	92.75%	88.73%	91.99%	91.11%	81.74%	84.36%
Interest Burden Percent	65.05%	62.93%	43.45%	63.00%	68.23%	66.03%
Effective Tax Rate	7.25%	11.27%	8.01%	8.89%	18.26%	15.65%
Return on Invested Capital (ROIC)	0.00%	18.32%	10.44%	14.98%	15.28%	12.35%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	6.86%	0.79%	5.45%	5.59%	5.40%
Return on Net Nonoperating Assets (RNNOA)	0.00%	27.07%	2.07%	8.13%	6.36%	9.78%
Return on Equity (ROE)	0.00%	45.39%	12.51%	23.11%	21.64%	22.13%
Cash Return on Invested Capital (CROIC)	0.00%	-181.69%	-2.71%	14.04%	-0.59%	-45.70%
Operating Return on Assets (OROA)	0.00%	2.79%	2.84%	4.80%	5.12%	4.89%
Return on Assets (ROA)	0.00%	1.56%	1.13%	2.76%	2.85%	2.72%
Return on Common Equity (ROCE)	0.00%	10.19%	5.71%	13.45%	12.50%	12.65%
Return on Equity Simple (ROE_SIMPLE)	0.00%	101.04%	16.47%	34.13%	34.74%	36.63%
Net Operating Profit after Tax (NOPAT)	94	141	172	264	294	361
NOPAT Margin	12.25%	13.82%	11.98%	15.29%	14.13%	14.35%
Net Nonoperating Expense Percent (NNEP)	0.00%	11.45%	9.65%	9.53%	9.68%	6.96%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	9.42%	9.92%	8.24%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	15.45%	10.55%	9.70%	11.42%	13.29%	13.99%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	86.79%	84.43%	86.97%	83.22%	82.72%	82.99%
Earnings before Interest and Taxes (EBIT)	105	126	142	284	349	413
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	159	199	266	410	484	611
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	19.17	60.21	44.53	39.54	26.77
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.75	1.31	14.45	12.35	10.65	6.68
Price to Earnings (P/E)	20.85	19.64	314.21	348.95	362.64	177.47
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.87%
Earnings Yield	4.80%	5.09%	0.32%	0.29%	0.28%	0.56%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.83	12.61	12.77	11.40	5.29
Enterprise Value to Revenue (EV/Rev)	0.00	2.75	15.43	13.10	11.38	7.93
Enterprise Value to EBITDA (EV/EBITDA)	0.00	14.11	83.19	55.05	48.89	32.62
Enterprise Value to EBIT (EV/EBIT)	0.00	22.21	156.03	79.44	67.82	48.31
Enterprise Value to NOPAT (EV/NOPAT)	0.00	19.93	128.77	85.66	80.57	55.26
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	20.71	80.83	67.34	49.56	38.73
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	91.40	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	5.10	2.67	2.42	2.02	2.99
Long-Term Debt to Equity	0.00	5.04	2.63	2.39	1.98	2.94
Financial Leverage	0.00	3.94	2.63	1.49	1.14	1.81
Leverage Ratio	0.00	14.58	11.03	8.38	7.58	8.13
Compound Leverage Factor	0.00	9.17	4.79	5.28	5.17	5.37
Debt to Total Capital	0.00%	83.61%	72.78%	70.80%	66.89%	74.93%
Short-Term Debt to Total Capital	0.00%	1.01%	1.07%	1.09%	1.20%	1.18%
Long-Term Debt to Total Capital	0.00%	82.60%	71.70%	69.70%	65.70%	73.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	12.71%	11.49%	12.12%	14.19%	10.74%
Common Equity to Total Capital	0.00%	3.68%	15.73%	17.08%	18.92%	14.33%
Debt to EBITDA	0.00	7.98	5.98	4.83	4.09	5.37
Net Debt to EBITDA	0.00	6.17	4.36	2.32	2.26	4.37
Long-Term Debt to EBITDA	0.00	7.88	5.90	4.76	4.02	5.29
Debt to NOPAT	0.00	11.27	9.26	7.52	6.74	9.10
Net Debt to NOPAT	0.00	8.71	6.74	3.61	3.73	7.40
Long-Term Debt to NOPAT	0.00	11.13	9.13	7.40	6.62	8.95
Altman Z-Score	0.00	0.51	2.92	2.87	2.68	1.63
Noncontrolling Interest Sharing Ratio	0.00%	77.54%	54.33%	41.80%	42.24%	42.86%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.00	1.03	1.24	1.16	1.05
Quick Ratio	0.00	0.20	0.20	0.39	0.30	0.20
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,396	-45	247	-11	-1,335
Operating Cash Flow to CapEx	0.00%	763.47%	77.49%	1,474.33%	1,602.64%	1,095.44%
Free Cash Flow to Firm to Interest Expense	0.00	-29.54	-0.56	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	4.21	2.87	3.45	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	4.34	2.49	-1.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.22	0.29	0.29	0.30	0.30
Accounts Receivable Turnover	0.00	5.73	7.39	7.81	7.91	7.36
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	58.44	87.60	74.10	56.38	54.31
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	63.70	49.42	46.72	46.17	49.62
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	0.00	63.70	49.42	46.72	46.17	49.62
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	1,536	1,752	1,769	2,074	3,770
Invested Capital Turnover	0.00	1.33	0.87	0.98	1.08	0.86
Increase / (Decrease) in Invested Capital	0.00	1,536	216	17	305	1,696
Enterprise Value (EV)	0.00	2,804	22,106	22,595	23,648	19,942
Market Capitalization	1,338	1,338	20,698	21,304	22,134	16,800
Book Value per Share	$0.00	$1.23	$0.66	$0.92	$1.08	$2.40
Tangible Book Value per Share	$0.00	($30.91)	($2.97)	($2.55)	($3.26)	($13.35)
Total Capital	0.00	1,896	2,185	2,800	2,959	4,381
Total Debt	0.00	1,585	1,590	1,982	1,979	3,283
Total Long-Term Debt	0.00	1,566	1,567	1,952	1,944	3,231
Net Debt	0.00	1,225	1,158	951	1,094	2,672
Capital Expenditures (CapEx)	-4.91	18	353	23	30	47
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-282	-271	-202	-212	-249
Debt-free Net Working Capital (DFNWC)	0.00	30	116	790	627	292
Net Working Capital (NWC)	0.00	11	93	760	591	240
Net Nonoperating Expense (NNE)	31	70	115	101	99	131
Net Nonoperating Obligations (NNO)	0.00	1,225	1,158	951	1,094	2,672
Total Depreciation and Amortization (D&A)	55	73	124	126	135	199
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-27.74%	-18.89%	-11.73%	-10.21%	-9.89%
Debt-free Net Working Capital to Revenue	0.00%	2.96%	8.12%	45.81%	30.16%	11.59%
Net Working Capital to Revenue	0.00%	1.08%	6.48%	44.04%	28.46%	9.53%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.07)	$0.57	$0.53	$0.78
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	259.06M	108.62M	114.36M	120.78M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.07)	$0.52	$0.52	$0.71
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	259.06M	265.75M	125.75M	132.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	($0.07)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	105.73M	519.30M	520.45M	261.91M
Normalized Net Operating Profit after Tax (NOPAT)	92	140	174	264	298	342
Normalized NOPAT Margin	12.06%	13.70%	12.17%	15.31%	14.34%	13.58%
Pre Tax Income Margin	8.89%	7.80%	4.30%	10.39%	11.45%	10.83%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	2.94	2.67	1.79	0.00	0.00	0.00
NOPAT to Interest Expense	2.64	2.98	2.16	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	3.08	2.30	-2.66	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	2.77	2.60	-2.28	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	24.43%	36.85%	80.53%
Augmented Payout Ratio	0.00%	0.00%	462.41%	24.43%	36.85%	80.53%

This table displays calculated financial ratios and metrics derived from Ryan Specialty's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.79%	14.92%	18.28%	19.10%	21.83%	22.49%	20.64%	18.85%	20.47%	24.52%
EBITDA Growth	96.69%	2,173.03%	53.83%	11.68%	13.93%	7.38%	3.65%	30.94%	16.34%	48.68%
EBIT Growth	296.68%	329.84%	95.79%	15.62%	13.58%	6.16%	0.96%	33.73%	-6.97%	31.23%
NOPAT Growth	10,852.08%	51.78%	3.43%	18.48%	-50.77%	35.56%	4.97%	31.57%	338.37%	-29.25%
Net Income Growth	189.84%	54.59%	101.69%	19.53%	-46.37%	27.79%	11.58%	40.83%	82.40%	-27.26%
EPS Growth	156.25%	66.67%	83.33%	18.18%	-144.44%	26.67%	18.18%	42.31%	325.00%	-36.84%
Operating Cash Flow Growth	-129.42%	54.91%	-143.18%	32.09%	868.55%	22.94%	26.80%	-10.93%	-4.32%	14.45%
Free Cash Flow Firm Growth	92.66%	0.00%	90.90%	88.02%	-83.08%	-490.52%	42.53%	-1,070.13%	-447.08%	-676.82%
Invested Capital Growth	10.59%	0.95%	12.04%	7.61%	13.60%	17.24%	7.54%	24.17%	64.12%	81.78%
Revenue Q/Q Growth	-16.14%	5.59%	5.19%	27.87%	-14.22%	6.16%	3.60%	25.98%	-13.05%	9.73%
EBITDA Q/Q Growth	-32.36%	20.68%	-9.08%	50.47%	-30.99%	13.75%	-12.25%	90.09%	-38.69%	45.36%
EBIT Q/Q Growth	-42.15%	31.91%	-13.31%	74.77%	-43.17%	23.29%	-17.56%	131.51%	-60.47%	73.92%
NOPAT Q/Q Growth	-39.64%	27.87%	-14.93%	80.45%	-74.92%	252.09%	-34.13%	126.18%	-16.43%	-43.18%
Net Income Q/Q Growth	-58.24%	56.36%	-20.37%	129.91%	-81.27%	272.56%	-30.47%	190.18%	-75.73%	48.57%
EPS Q/Q Growth	-59.09%	66.67%	-26.67%	136.36%	-115.38%	575.00%	-31.58%	184.62%	-75.68%	33.33%
Operating Cash Flow Q/Q Growth	-105.96%	1,444.29%	-186.28%	290.97%	-65.30%	115.04%	-151.37%	332.39%	-62.73%	157.22%
Free Cash Flow Firm Q/Q Growth	45.76%	143.28%	-404.71%	83.26%	-729.09%	7.68%	55.16%	-240.92%	-287.64%	-31.08%
Invested Capital Q/Q Growth	5.07%	-5.32%	17.49%	-7.94%	10.93%	-2.29%	7.78%	6.30%	46.62%	8.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	22.65%	25.89%	22.37%	26.33%	21.18%	22.69%	19.22%	29.01%	20.45%	27.09%
Operating Margin	14.89%	18.22%	15.32%	20.99%	13.91%	18.08%	13.16%	23.64%	13.47%	16.48%
EBIT Margin	14.91%	18.62%	15.35%	20.97%	13.90%	16.14%	12.84%	23.60%	10.73%	17.01%
Profit (Net Income) Margin	7.11%	10.52%	7.97%	14.32%	3.13%	10.98%	7.37%	16.97%	4.74%	6.41%
Tax Burden Percent	89.57%	88.65%	85.28%	87.80%	38.74%	98.86%	86.36%	86.33%	145.54%	61.64%
Interest Burden Percent	53.23%	63.75%	60.88%	77.78%	58.11%	68.81%	66.44%	83.30%	30.33%	61.18%
Effective Tax Rate	10.43%	11.35%	14.72%	12.20%	61.26%	1.14%	13.64%	13.67%	-45.54%	38.36%
Return on Invested Capital (ROIC)	12.51%	15.82%	11.93%	18.87%	5.35%	19.32%	11.44%	21.71%	16.68%	8.74%
ROIC Less NNEP Spread (ROIC-NNEP)	10.22%	13.50%	10.03%	16.52%	4.36%	15.73%	9.67%	19.61%	11.64%	7.42%
Return on Net Nonoperating Assets (RNNOA)	17.49%	20.16%	16.71%	20.55%	5.88%	17.90%	13.17%	22.09%	20.30%	13.46%
Return on Equity (ROE)	30.00%	35.98%	28.63%	39.41%	11.22%	37.23%	24.62%	43.81%	36.99%	22.20%
Cash Return on Invested Capital (CROIC)	0.00%	14.04%	2.66%	8.53%	0.78%	-0.59%	6.48%	-6.12%	-34.70%	-45.70%
Operating Return on Assets (OROA)	4.72%	5.43%	4.78%	5.80%	4.54%	4.92%	4.24%	6.95%	3.43%	5.06%
Return on Assets (ROA)	2.25%	3.07%	2.48%	3.96%	1.02%	3.35%	2.43%	5.00%	1.52%	1.91%
Return on Common Equity (ROCE)	17.26%	20.94%	17.08%	23.19%	6.51%	21.50%	14.33%	25.30%	21.29%	12.69%
Return on Equity Simple (ROE_SIMPLE)	33.22%	0.00%	35.71%	34.95%	33.47%	0.00%	35.84%	38.45%	38.85%	0.00%
Net Operating Profit after Tax (NOPAT)	55	70	60	108	27	95	63	142	119	67
NOPAT Margin	13.34%	16.15%	13.06%	18.43%	5.39%	17.87%	11.36%	20.40%	19.61%	10.15%
Net Nonoperating Expense Percent (NNEP)	2.29%	2.32%	1.90%	2.35%	0.99%	3.59%	1.77%	2.10%	5.05%	1.32%
Return On Investment Capital (ROIC_SIMPLE)	-	2.51%	-	-	-	3.22%	-	-	-	1.54%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	11.89%	13.13%	11.30%	13.95%	13.80%	13.81%	13.74%	11.93%	14.67%	15.75%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	85.11%	81.78%	84.68%	79.01%	86.09%	81.92%	86.84%	76.36%	86.53%	83.52%
Earnings before Interest and Taxes (EBIT)	61	81	70	123	70	86	71	164	65	113
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	93	113	102	154	106	121	106	202	124	180
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	47.16	44.53	40.68	41.31	45.93	39.54	51.92	49.71	54.86	26.77
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	12.51	12.35	11.52	12.22	12.60	10.65	13.25	13.19	14.56	6.68
Price to Earnings (P/E)	392.41	348.95	307.39	316.83	444.63	362.64	446.81	371.23	334.58	177.47
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.42%	0.59%	0.68%	0.87%
Earnings Yield	0.25%	0.29%	0.33%	0.32%	0.22%	0.28%	0.22%	0.27%	0.30%	0.56%
Enterprise Value to Invested Capital (EV/IC)	11.94	12.77	10.71	12.77	12.49	11.40	13.63	13.42	10.78	5.29
Enterprise Value to Revenue (EV/Rev)	13.37	13.10	12.39	12.94	13.39	11.38	14.02	13.97	15.75	7.93
Enterprise Value to EBITDA (EV/EBITDA)	76.29	55.05	49.88	52.87	55.78	48.89	62.50	59.59	68.00	32.62
Enterprise Value to EBIT (EV/EBIT)	132.62	79.44	69.82	72.89	77.15	67.82	87.19	81.59	97.34	48.31
Enterprise Value to NOPAT (EV/NOPAT)	93.04	85.66	80.75	83.50	98.28	80.57	102.70	96.27	96.76	55.26
Enterprise Value to Operating Cash Flow (EV/OCF)	82.58	67.34	92.06	77.44	60.98	49.56	58.59	65.52	77.92	38.73
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	91.40	425.74	155.21	1,695.88	0.00	217.83	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.62	2.42	2.32	2.10	2.10	2.02	2.03	1.84	2.43	2.99
Long-Term Debt to Equity	2.58	2.39	2.29	2.06	2.07	1.98	1.99	1.81	2.40	2.94
Financial Leverage	1.71	1.49	1.67	1.24	1.35	1.14	1.36	1.13	1.74	1.81
Leverage Ratio	8.03	8.38	7.82	8.31	7.13	7.58	7.21	7.69	7.30	8.13
Compound Leverage Factor	4.28	5.34	4.76	6.47	4.14	5.22	4.79	6.40	2.21	4.97
Debt to Total Capital	72.35%	70.80%	69.85%	67.71%	67.79%	66.89%	67.03%	64.78%	70.87%	74.93%
Short-Term Debt to Total Capital	1.06%	1.09%	0.80%	1.05%	1.22%	1.20%	1.33%	1.08%	0.88%	1.18%
Long-Term Debt to Total Capital	71.29%	69.70%	69.05%	66.66%	66.57%	65.70%	65.70%	63.70%	69.99%	73.75%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	11.49%	12.12%	12.14%	13.17%	13.63%	14.19%	14.22%	15.34%	12.39%	10.74%
Common Equity to Total Capital	16.16%	17.08%	18.01%	19.12%	18.58%	18.92%	18.75%	19.88%	16.74%	14.33%
Debt to EBITDA	6.78	4.83	4.42	4.28	4.17	4.09	4.07	3.69	4.85	5.37
Net Debt to EBITDA	3.80	2.32	2.75	2.10	2.49	2.26	2.59	2.43	4.31	4.37
Long-Term Debt to EBITDA	6.68	4.76	4.37	4.21	4.09	4.02	3.99	3.63	4.79	5.29
Debt to NOPAT	8.27	7.52	7.16	6.76	7.34	6.74	6.68	5.96	6.90	9.10
Net Debt to NOPAT	4.63	3.61	4.45	3.31	4.38	3.73	4.25	3.93	6.14	7.40
Long-Term Debt to NOPAT	8.15	7.40	7.08	6.66	7.21	6.62	6.55	5.86	6.82	8.95
Altman Z-Score	3.02	2.76	2.88	2.68	3.21	2.56	3.26	2.93	3.16	1.53
Noncontrolling Interest Sharing Ratio	42.45%	41.80%	40.33%	41.16%	41.97%	42.24%	41.80%	42.26%	42.44%	42.86%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.27	1.24	1.25	1.22	1.20	1.16	1.15	1.09	1.01	1.05
Quick Ratio	0.41	0.39	0.34	0.33	0.33	0.30	0.26	0.21	0.14	0.20
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-124	54	-164	-27	-227	-210	-94	-321	-1,243	-1,629
Operating Cash Flow to CapEx	-262.52%	1,719.60%	-5,700.36%	11,835.23%	990.51%	1,648.39%	-1,527.78%	1,808.29%	1,421.69%	1,501.16%
Free Cash Flow to Firm to Interest Expense	-4.30	0.00	-5.55	-0.95	0.00	0.00	-3.20	-10.30	0.00	0.00
Operating Cash Flow to Interest Expense	-0.48	0.00	-5.40	10.53	0.00	0.00	-3.96	8.70	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-0.66	0.00	-5.50	10.44	0.00	0.00	-4.22	8.22	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.32	0.29	0.31	0.28	0.33	0.30	0.33	0.29	0.32	0.30
Accounts Receivable Turnover	9.29	7.81	8.47	6.92	9.29	7.91	8.14	6.66	8.32	7.36
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	88.52	74.10	77.27	77.80	72.15	56.38	58.31	58.47	61.22	54.31
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	39.27	46.72	43.11	52.71	39.28	46.17	44.85	54.81	43.88	49.62
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	39.27	46.72	43.11	52.71	39.28	46.17	44.85	54.81	43.88	49.62
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,868	1,769	2,078	1,914	2,123	2,074	2,235	2,376	3,484	3,770
Invested Capital Turnover	0.94	0.98	0.91	1.02	0.99	1.08	1.01	1.06	0.85	0.86
Increase / (Decrease) in Invested Capital	179	17	223	135	254	305	157	462	1,361	1,696
Enterprise Value (EV)	22,305	22,595	22,258	24,445	26,517	23,648	30,461	31,884	37,566	19,942
Market Capitalization	20,879	21,304	20,688	23,090	24,937	22,134	28,780	30,114	34,715	16,800
Book Value per Share	$0.85	$0.92	$0.98	$1.08	$1.04	$1.08	$4.71	$1.16	$1.21	$2.40
Tangible Book Value per Share	($2.64)	($2.55)	($2.67)	($2.53)	($3.13)	($3.26)	($14.30)	($3.61)	($5.85)	($13.35)
Total Capital	2,740	2,800	2,824	2,923	2,922	2,959	2,957	3,047	3,781	4,381
Total Debt	1,983	1,982	1,973	1,979	1,981	1,979	1,982	1,974	2,680	3,283
Total Long-Term Debt	1,953	1,952	1,950	1,949	1,945	1,944	1,943	1,941	2,647	3,231
Net Debt	1,111	951	1,227	970	1,181	1,094	1,260	1,303	2,382	2,672
Capital Expenditures (CapEx)	5.23	11	2.79	2.57	11	14	7.63	15	7.10	17
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-122	-202	20	-104	-114	-212	-87	-153	-148	-249
Debt-free Net Working Capital (DFNWC)	711	790	725	862	640	627	578	459	87	292
Net Working Capital (NWC)	682	760	702	832	605	591	539	426	53	240
Net Nonoperating Expense (NNE)	26	24	23	24	11	37	22	24	90	25
Net Nonoperating Obligations (NNO)	1,111	951	1,227	970	1,181	1,094	1,260	1,303	2,382	2,672
Total Depreciation and Amortization (D&A)	32	32	32	31	37	35	35	38	59	67
Debt-free, Cash-free Net Working Capital to Revenue	-7.32%	-11.73%	1.12%	-5.48%	-5.77%	-10.21%	-4.01%	-6.71%	-6.22%	-9.89%
Debt-free Net Working Capital to Revenue	42.60%	45.81%	40.36%	45.64%	32.34%	30.16%	26.63%	20.13%	3.64%	11.59%
Net Working Capital to Revenue	40.85%	44.04%	39.11%	44.02%	30.54%	28.46%	24.82%	18.68%	2.24%	9.53%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.11	$0.16	$0.12	$0.27	($0.04)	$0.18	$0.14	$0.38	$0.15	$0.11
Adjusted Weighted Average Basic Shares Outstanding	109.43M	108.62M	111.03M	112.92M	115.87M	114.36M	117.81M	118.39M	121.92M	120.78M
Adjusted Diluted Earnings per Share	$0.09	$0.15	$0.11	$0.26	($0.04)	$0.19	$0.13	$0.37	$0.09	$0.12
Adjusted Weighted Average Diluted Shares Outstanding	266.35M	265.75M	266.98M	123.85M	115.87M	125.75M	269.92M	271.22M	272.69M	132.89M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	519.21M	519.30M	519.56M	520.43M	520.50M	520.45M	520.89M	522.90M	261.84M	261.91M
Normalized Net Operating Profit after Tax (NOPAT)	55	71	60	109	50	96	63	143	57	53
Normalized NOPAT Margin	13.43%	16.41%	13.19%	18.70%	9.99%	18.07%	11.35%	20.56%	9.39%	7.96%
Pre Tax Income Margin	7.93%	11.87%	9.34%	16.32%	8.07%	11.11%	8.53%	19.66%	3.25%	10.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.13	0.00	2.38	4.25	0.00	0.00	2.41	5.27	0.00	0.00
NOPAT to Interest Expense	1.90	0.00	2.03	3.73	0.00	0.00	2.13	4.56	0.00	0.00
EBIT Less CapEx to Interest Expense	1.95	0.00	2.29	4.16	0.00	0.00	2.15	4.79	0.00	0.00
NOPAT Less CapEx to Interest Expense	1.72	0.00	1.93	3.65	0.00	0.00	1.87	4.08	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	24.43%	22.00%	24.67%	32.92%	36.85%	58.91%	62.69%	68.39%	80.53%
Augmented Payout Ratio	0.00%	24.43%	22.00%	24.67%	32.92%	36.85%	58.91%	62.69%	68.39%	80.53%

Frequently Asked Questions About Ryan Specialty's Financials

When does Ryan Specialty's financial year end?

According to the most recent income statement we have on file, Ryan Specialty's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Ryan Specialty's net income changed over the last 5 years?

Ryan Specialty's net income appears to be on an upward trend, with a most recent value of $229.91 million in 2024, rising from $63.06 million in 2019. The previous period was $194.48 million in 2023.

What is Ryan Specialty's operating income?

Ryan Specialty's total operating income in 2024 was $427.81 million, based on the following breakdown:

Total Gross Profit: $2.52 billion
Total Operating Expenses: $2.09 billion

How has Ryan Specialty revenue changed over the last 5 years?

Over the last 5 years, Ryan Specialty's total revenue changed from $765.11 million in 2019 to $2.52 billion in 2024, a change of 228.8%.

How much debt does Ryan Specialty have?

Ryan Specialty's total liabilities were at $8.55 billion at the end of 2024, a 36.4% increase from 2023, and a 102.7% increase since 2020.

How much cash does Ryan Specialty have?

In the past 4 years, Ryan Specialty's cash and equivalents has ranged from $312.65 million in 2020 to $992.72 million in 2022, and is currently $540.20 million as of their latest financial filing in 2024.

How has Ryan Specialty's book value per share changed over the last 5 years?

Over the last 5 years, Ryan Specialty's book value per share changed from 0.00 in 2019 to 2.40 in 2024, a change of 239.7%.

Remove Ads

Related Companies

This page (NYSE:RYAN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ryan Specialty (RYAN) Financials

Frequently Asked Questions About Ryan Specialty's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ryan Specialty (RYAN) Financials

Annual Income Statements for Ryan Specialty

Quarterly Income Statements for Ryan Specialty

Annual Cash Flow Statements for Ryan Specialty

Quarterly Cash Flow Statements for Ryan Specialty

Annual Balance Sheets for Ryan Specialty

Quarterly Balance Sheets for Ryan Specialty

Annual Metrics and Ratios for Ryan Specialty

Quarterly Metrics and Ratios for Ryan Specialty

Frequently Asked Questions About Ryan Specialty's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools